Algorithmiq is a quantum software company that develops quantum-enhanced software algorithms for the life sciences sector to assist in the development of novel drugs and materials, by leveraging quantum chemistry, computational physics, and complex systems. The company’s algorithms are reportedly capable of accelerating chemical simulations run on near-term quantum computers and noisy intermediate-scale quantum (NISQ) devices by 100x in comparison to existing supercomputers.
The company’s quantum-enhanced drug discovery platform is capable of working with any qubit technology and can be used on major quantum cloud platforms including that of IBM, Microsoft, and IonQ. It also operates an online quantum information and science learning platform called QPlayLearn to educate users on quantum technologies across various levels regardless of age and expertise.
Key customers and partnerships
In November 2022, the company partnered with IBM to enhance its study of quantum algorithms in the life sciences.
Funding and financials
In June 2023, the company raised EUR 13.7 million (USD 15 million) in a Series A funding round led by Inventure VC. The funds were earmarked to pursue global collaborations with pharmaceutical companies.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.